Characteristic and Real Intensity of Exercise in a Hospital-based Physical Activity Protocol for Patients With Chronic Disease

February 23, 2023 updated by: Edem ALLADO, Central Hospital, Nancy, France

The objective is to better characterize an adapted physical activity (APA) program within of the management of chronic diseases.

In France, since 2016, medical doctors have been able to prescribe APA to their patients with chronic diseases but while there are indeed prescription recommendations, there is no clear characterization of the practical reality of APA programs.

The interest of this work is to benefit from the experience of the Center of Sports Medicine and Adapted Physical Activities in Nancy (France) specifically dedicated to the prescription and the initiation of an APA program for of patients with a chronic disease.

Thus, this work aims to determine the real intensity of the APA, the effectiveness of the assessment necessary for the dispensation of the APA and other parameters likely to modify the result of the treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

240

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vandoeuvre les nancy, France, 54500
        • Centre Hospitalier Régional Universitaire de Nancy.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This is a cross-sectional monocentric study performed at the Nancy University Center of Sports Medicine and APA, France, between February 2020 and July 2021, in patients requiring implementation of APA.

Description

Inclusion Criteria:

- age greater than 18 years old, with the ability to perform a cardiopulmonary exercise test

Exclusion Criteria:

  • beta-blocker treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
No limitation of exercise performance capacities
normal maximal oxygen uptake (greater than or equal to 80% of the reference value)
During the APA session, HR was digitized at 1Hz (using custo guard, Custo Med GmbH). The ratio between the APA session HR and exercise test HRpeak was used to assess the intensity of effort.
Limitation of exercise performance capacities
reduced maximal oxygen uptake (less than 80% of the reference value).
During the APA session, HR was digitized at 1Hz (using custo guard, Custo Med GmbH). The ratio between the APA session HR and exercise test HRpeak was used to assess the intensity of effort.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
evaluate the real intensity level of adapted physical activity (APA).
Time Frame: Heart rate mean during 1 hour in the first APA Session (cross-sectional monocentric study)
evaluate the real intensity level of exercise in a sample of patients with chronic disease involved in a hospital-based program of adapted physical activity (APA).
Heart rate mean during 1 hour in the first APA Session (cross-sectional monocentric study)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate Six-Minute Walk Test (6-MWT) efficacity to determine physical activity capacities
Time Frame: 6 minutes in the first APA Session (cross-sectional monocentric study)
evaluate Six-Minute Walk Test (6-MWT) efficacity to determine physical activity capacities for patients with chronic disease.
6 minutes in the first APA Session (cross-sectional monocentric study)
Evaluate sit-to-stand test (1 minute)) efficacity to determine physical activity capacities
Time Frame: 1 minute in the first APA Session (cross-sectional monocentric study)
Evaluate sit-to-stand test (1 minute)) efficacity to determine physical activity capacitiesfor patients with chronic disease.
1 minute in the first APA Session (cross-sectional monocentric study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

November 9, 2021

First Submitted That Met QC Criteria

December 3, 2021

First Posted (Actual)

December 6, 2021

Study Record Updates

Last Update Posted (Estimate)

February 27, 2023

Last Update Submitted That Met QC Criteria

February 23, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-PI191

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Inactivity

Clinical Trials on Heart Rate Recording

Subscribe